Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Unlocked and loaded: Families confront dementia and guns

With a bullet in her gut, her voice choked with pain, Dee Hill pleaded with the 911 dispatcher for help.

25 Jun 2018

Eye could be a surrogate for brain degeneration like AD

Researchers from Queen's University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer's disease (AD).

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

ABPI associated with NHS for 70 years in pharmaceutical research

In this special year, both the NHS and the Association of the British Pharmaceutical Industry are celebrating our respective 70th anniversaries. The histories of these two organizations have been inextricably linked since 1948 and our relationship with the NHS continues to go from strength to strength.

25 Jun 2018

Coffee and the heart – four strong cups a day is beneficial finds study

According to a new study four cups of strong coffee might be the amount that would keep the hearts of older adults healthy. The latest study titled, “CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system—New mode of action for caffeine,” was published on 21st of June 2018 in the journal PLOS Biology.

25 Jun 2018

Pioneering exercise program improves physical, mental health of elderly people living in care homes

If the number of people over 65 currently accounts for 22% of the total population in the Basque Autonomous Community (region), predictions indicate that this percentage will rise to 30% by 2030.

22 Jun 2018

Scientists develop unique program to predict a form of Parkinson's disease

Russian scientists develop a "predictor" of Parkinson's disease forms

22 Jun 2018

Herpes may play role in pathogenesis of Alzheimer’s

Herpes virus present within the body long after the overt infection may play a role in the pathogenesis of Alzheimer’s disease say researchers. The study titled, “Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus” appeared in the latest issue of the journal Neuron, this Thursday.

22 Jun 2018

'Antifreeze' molecules may hold key to better treatments for brain injuries

The key to better treatments for brain injuries and disease may lie in the molecules charged with preventing the clumping of specific proteins associated with cognitive decline and other neurological problems, researchers from the Perelman School of Medicine at the University of Pennsylvania report in a new study published in Neurobiology of Disease.

22 Jun 2018

Massive analysis of genomes reveals insights into genetic overlap among psychiatric diseases

A massive undertaking by the Brainstorm Consortium to analyze the genomes of nearly 900,000 people has revealed important insights into the genetic overlap among some psychiatric diseases, as well as among personality traits.

21 Jun 2018

Researchers report unusually high levels of herpesvirus in the brains of people with Alzheimer's disease

Two strains of human herpesvirus - human herpesvirus 6A (HHV-6A) and human herpesvirus 7 (HHV-7) - are found in the brains of people with Alzheimer's disease at levels up to twice as high as in those without Alzheimer's, researchers from the Icahn School of Medicine at Mount Sinai report.

21 Jun 2018

Breakthrough discovery reveals brain metals that may drive progression of Alzheimer’s disease

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.

21 Jun 2018

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

21 Jun 2018

Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment

An international team of scientists have developed a new way to screen for age-related cognitive decline at home using a test which asks people to detect sounds and flashes on their laptop or phone.

21 Jun 2018

Impulse control disorders found to be more common in people taking Parkinson's drugs

Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

20 Jun 2018

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

In what researchers are calling a game changer for future ataxia treatments, a new study showed the ability to turn down the disease progression of the most common dominantly inherited ataxia.

20 Jun 2018

Researchers invent medical device for proliferation, differentiation of neural stem cells

The research team of Hong Kong Baptist University invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells in vitro.

20 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

Scientists obtain key information about proteins from single human cells

Scientists have obtained a slew of key information about proteins, the molecular workhorses of all cells, from single human cells for the first time.

19 Jun 2018

Study hints at benefits of lifestyle interventions in reducing dementia risk

There is no treatment yet for dementia; but one day, a family doctor could prescribe a specific diet, an exercise regime, music or language lessons, or documentary discussion groups as treatments to ward off the disease.

19 Jun 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Unlocked and loaded: Families confront dementia and guns

Eye could be a surrogate for brain degeneration like AD

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

ABPI associated with NHS for 70 years in pharmaceutical research

Coffee and the heart – four strong cups a day is beneficial finds study

Pioneering exercise program improves physical, mental health of elderly people living in care homes

Scientists develop unique program to predict a form of Parkinson's disease

Herpes may play role in pathogenesis of Alzheimer’s

'Antifreeze' molecules may hold key to better treatments for brain injuries

Massive analysis of genomes reveals insights into genetic overlap among psychiatric diseases

Researchers report unusually high levels of herpesvirus in the brains of people with Alzheimer's disease

Breakthrough discovery reveals brain metals that may drive progression of Alzheimer’s disease

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment

Impulse control disorders found to be more common in people taking Parkinson's drugs

Researchers employ nucleotide-based gene silencing to mitigate common ataxia

Researchers invent medical device for proliferation, differentiation of neural stem cells

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

Scientists obtain key information about proteins from single human cells

Study hints at benefits of lifestyle interventions in reducing dementia risk

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in